Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Baranyi, A; Amouzadeh-Ghadikolai, O; von Lewinski, D; Rothenhäusler, HB; Theokas, S; Robier, C; Mangge, H; Reicht, G; Hlade, P; Meinitzer, A.
Branched-Chain Amino Acids as New Biomarkers of Major Depression - A Novel Neurobiology of Mood Disorder.
PLoS One. 2016; 11(8):e0160542-e0160542
Doi: 10.1371/journal.pone.0160542
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Baranyi Andreas
- von Lewinski Dirk
- Co-Autor*innen der Med Uni Graz
- Mangge Harald
- Meinitzer Andreas
- Robier Christoph
- Rothenhäusler Hans-Bernd
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The proteinogenic branched-chain amino acids (BCAAs) valine, leucine and isoleucine might play an unrecognised crucial role in the development of depression through their activation of the mammalian target of rapamycin (mTor) pathway. The aim of this research project is to evaluate whether BCAAs are altered in patients with major depression and might thus be appropriate biomarkers for major depression. The concentrations of valine, leucine and isoleucine were determined in 71 in-patients with major depression and 48 healthy controls by high-pressure liquid chromatography. Psychiatric and laboratory assessments were obtained at the time of in-patient admittance. The BCAAs are significantly decreased in patients with major depression in comparison with healthy subjects (valine: Mann-Whitney-U: 968.0; p <0.0001, leucine: Mann-Whitney-U: 1246.5; p = 0.013, isoleucine: Mann-Whitney-U: 1252.5; p = 0.014). Furthermore, as shown by Spearman's rank correlation coefficients, there is a significant negative correlation between valine, leucine and isoleucine concentrations and the Hamilton Depression Rating Scale (HAMD-17) as well as Beck Depression Inventory (BDI-II) scores. Our study results are strong evidence that in patients with major depression, BCAAs might be appropriate biomarkers for depression. Reduced activation of the mammalian target of rapamycin (mTor) due to a reduction of BCAAs might play a crucial unrecognised factor in the etiology of depression and may evoke depressive symptomatology and lower energy metabolism in patients with major depression. In the future, mTor and its up- and downstream signalling partners might be important targets for the development of novel antidepressants.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Amino Acids, Branched-Chain - analysis
- Biomarkers - analysis
- Case-Control Studies -
- Chromatography, High Pressure Liquid -
- Depressive Disorder, Major - diagnosis
- Depressive Disorder, Major - metabolism
- Depressive Disorder, Major - pathology
- Down-Regulation -
- Energy Metabolism -
- Female -
- Humans -
- Isoleucine - chemistry
- Isoleucine - metabolism
- Leucine - chemistry
- Leucine - metabolism
- Male -
- Middle Aged -
- Mood Disorders - metabolism
- Mood Disorders - pathology
- Nervous System - metabolism
- TOR Serine-Threonine Kinases - metabolism
- Valine - chemistry
- Valine - metabolism